References
- Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9:59–62.
- Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, van Damme P, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol. 2012; 19:360–75.
- Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
- Cazzolli PA, Brooks BR, Lewarski JL, McKim DA, Chatburn RL. Oral Secretion Scale (OSS) Score in amyotrophic lateral sclerosis patients is associated with tolerance of non-invasive positive pressure ventilation, need for hospice or transition to tracheal positive pressure ventilation (TPPV) and survival (abstract from a poster presentation at the 21st Symposium on ALS/MND, Orlando, USA, 2010). Amyotroph Lateral Scler. 2010;11 (Suppl 1):140.
- Arbouw ME, Movig KL, Koopmann M, Poels PJ, Guchelaar HJ, Egberts TC, et al. Glycopyrrolate for sialorrhea in Parkinson's disease: a randomized, double-blind, crossover trial. Neurology. 2010;74:1203–7.
- Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med. 2000; 154:1214–8.
- Nakayama Y, Ogura A, Matsuda C, Shimizu T, Cazzolli P, Brooks BR. Oral Secretion Scale – Test-re-test Reliablity Pilot Study in a Japanese Amyotrophic Lateral Sclerosis Population (abstract from a poster presentation at the 21stSymposium on ALS/MND, Orlando, USA, 2010). Amyotroph Lateral Scler. 2010;11(Suppl 1):141.
- Maclure M, Willett WC. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol. 1987;126:161–9.